Delivering on our core value of sharing genomics and therapeutics expertise across borders, we have launched the RIGHT program in 2025.

With Jordan being selected as the first international destination, we have established local strategic and scientific partnerships to ensure access, continuity and growth of the program both in country and region. 

We welcome entities who have interest in collaboration or partnership.